Efficacy and safety of high-flow oxygen therapy using an asymmetric nasal cannula for postextubation respiratory failure in patients at risk of reintubation. (Efficacy and safety of high-flow oxygen therapy using an asymmetric nasal cannula for postextubation respiratory failure in patients at risk of reintubation.)

未提供0 个研究点目标入组 30 人开始时间: 待定最近更新: 2025年5月8日

适应症

试验速览

暂无简介。

•(1) Patients admitted to an intensive care unit (ICU) who are intubated due to a medical condition and have at least one risk item for reintubation after extubation.
•(2) Patients who are 18 years of age or older at the time of consent.
•(3) Patients who have received a thorough explanation of their participation in this study, and who have obtained written consent from the patient or the patient's surrogate, based on sufficient understanding.

•(1) Patients intubated for respiratory management associated with surgical procedures (surgical procedures, traumatic diseases, poisoning, burns, etc.)
•(2) Patients receiving continuous oxygen administration via nasal cannula (home oxygen therapy
•(3) Patients with a history of pneumothorax
•(4) Patients without spontaneous respiration
•(5) Patients with obstruction of the nasal passages due to abnormalities of the nasal mucosa, etc.
•(6) Patients with a history of CSF leakage or head injury
•(7) Patients with cribriform plate abnormalities
•(8) Patients with pneumoencephalopathy, pneumothorax, cystic lung disease, or pathological hypotension
•(9) Patients with upper airway bypass
•(10) Patients participating in clinical trials or other clinical studies
•(11) Other patients who are deemed inappropriate as research subjects by the principal investigators and subinvestigators.

Improvement of respiratory workload: tidal volume (derived from deltaZ measured by EIT)

发起方

未提供